Heterologous strain challenge of cattle immunized with Anaplasma marginale outer membranes
- PMID: 7810060
- DOI: 10.1016/0165-2427(94)90072-8
Heterologous strain challenge of cattle immunized with Anaplasma marginale outer membranes
Abstract
In this study, we tested the hypothesis that outer membrane immunization would induce protection against an antigenically variant strain. Outer membranes were isolated from the Virginia strain of Anaplasma marginale using density gradient centrifugation, combined with saponin adjuvant, and used to immunize Friesian cattle in Zimbabwe. Immunized cattle developed high antibody titers (80,000-160,000) against outer membrane polypeptides including MSP-2 and MSP-5 in both the homologous Virginia and heterologous Zimbabwe strains. Outer membrane immunized cattle were protected significantly following challenge with 10(4) Zimbabwe strain parasitized erythrocytes, demonstrated by significant differences in prepatent period and peak rickettsemia compared with adjuvant immunized control cattle. One outer membrane immunized animal was completely protected against infection. However, there were no overall significant differences in severity of anemia between cattle immunized with outer membrane and the control group, indicating that a significant reduction in rickettsemia does not necessarily result in less severe anemia.
Similar articles
-
Induction of protective immunity by using Anaplasma marginale initial body membranes.Infect Immun. 1991 Sep;59(9):3199-204. doi: 10.1128/iai.59.9.3199-3204.1991. Infect Immun. 1991. PMID: 1715323 Free PMC article.
-
CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge.Infect Immun. 1998 Nov;66(11):5406-13. doi: 10.1128/IAI.66.11.5406-5413.1998. Infect Immun. 1998. PMID: 9784551 Free PMC article.
-
Immunization of cattle with Anaplasma marginale derived from tick cell culture.Vet Parasitol. 2001 Dec 3;102(1-2):151-61. doi: 10.1016/s0304-4017(01)00519-2. Vet Parasitol. 2001. PMID: 11705661 Clinical Trial.
-
Strategies to interrupt the development of Anaplasma marginale in its tick vector. The effect of bovine-derived antibodies.Ann N Y Acad Sci. 1996 Jul 23;791:157-65. doi: 10.1111/j.1749-6632.1996.tb53522.x. Ann N Y Acad Sci. 1996. PMID: 8784497 Review.
-
Immunity following use of Australian tick fever vaccine: a review of the evidence.Aust Vet J. 2001 Dec;79(12):832-9. doi: 10.1111/j.1751-0813.2001.tb10931.x. Aust Vet J. 2001. PMID: 11837905 Review.
Cited by
-
Adaptive immunity to Anaplasma pathogens and immune dysregulation: implications for bacterial persistence.Comp Immunol Microbiol Infect Dis. 2012 May;35(3):241-52. doi: 10.1016/j.cimid.2011.12.002. Epub 2012 Jan 4. Comp Immunol Microbiol Infect Dis. 2012. PMID: 22226382 Free PMC article. Review.
-
Expression of major surface protein 2 antigenic variants during acute Anaplasma marginale rickettsemia.Infect Immun. 1996 Mar;64(3):836-41. doi: 10.1128/iai.64.3.836-841.1996. Infect Immun. 1996. PMID: 8641789 Free PMC article.
-
Anaplasma marginale type IV secretion system proteins VirB2, VirB7, VirB11, and VirD4 are immunogenic components of a protective bacterial membrane vaccine.Infect Immun. 2010 Mar;78(3):1314-25. doi: 10.1128/IAI.01207-09. Epub 2010 Jan 11. Infect Immun. 2010. PMID: 20065028 Free PMC article.
-
Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.Curr Microbiol. 2014 Mar;68(3):269-77. doi: 10.1007/s00284-013-0475-6. Epub 2013 Oct 15. Curr Microbiol. 2014. PMID: 24126603
-
Physical linkage of naturally complexed bacterial outer membrane proteins enhances immunogenicity.Infect Immun. 2008 Mar;76(3):1223-9. doi: 10.1128/IAI.01356-07. Epub 2007 Dec 17. Infect Immun. 2008. PMID: 18086812 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials